Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

被引:35
作者
Abramson, David H. [1 ,2 ]
Marr, Brian P. [1 ,2 ]
Francis, Jasmine H. [1 ,2 ]
Dunkel, Ira J. [3 ,4 ]
Fabius, Armida W. M. [1 ,5 ]
Brodie, Scott E. [1 ,6 ]
Mondesire-Crump, Ijah [1 ]
Gobin, Y. Pierre [1 ,7 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[2] New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA
[4] New York Presbyterian Hosp, Dept Pediat, Weill Cornell Med Coll, New York, NY USA
[5] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[6] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA
[7] New York Presbyterian Hosp, Dept Radiol, Weill Cornell Med Coll, New York, NY USA
关键词
INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; SUBCONJUNCTIVAL CARBOPLATIN; RETINAL FUNCTION; PHASE-I/II; MELPHALAN; TOPOTECAN; MANAGEMENT; DELIVERY;
D O I
10.1371/journal.pone.0156806
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Report on the 7-year experience with bilateral ophthalmic artery chemosurgery (OAC-Tandem therapy) for bilateral retinoblastoma. Design Retrospective, single institution study. Subjects 120 eyes of 60 children with bilateral retinoblastoma treated since March 2008. Methods Retrospective review of all children treated at Memorial Sloan Kettering with bilateral ophthalmic artery chemosurgery (Melphalan, Carboplatin, Topotecan, Methotrexate) delivered in the same initial session to both naive and previously treated eyes. Main Outcome Measures Ocular survival, metastatic disease, patient survival from metastases, second cancers, systemic adverse effects, need for transfusion of blood products, electroretinogram before and after treatment. Results 116 eyes were salvaged (4 eyes were enucleated: 3 because of progressive disease, 1 family choice). Kaplan Meier ocular survival was 99.2% at one year, 96.9% at 2 and 3 years and 94.9% for years 4 through 7. There were no cases of metastatic disease or metastatic deaths with a mean follow-up of 3.01 years. Two children developed second cancers (both pineoblastoma) and one of them died. Transfusion of blood products was required in 3 cases (4 transfusions), 1.9%. Two children developed fever/neutropenia requiring hospitalization (0.95%). ERGs were improved in 21.6% and unchanged after treatment in 52.5% of cases (increase or decrease of less than 25 mu V). Conclusions Bilateral ophthalmic artery chemosurgery is a safe and effective technique for managing bilateral retinoblastoma-even when eyes are advanced bilaterally, and if both eyes have progressed after systemic chemotherapy. Ocular survival was excellent (94.9% at 8 years), there were no cases of of metastatic disease and no deaths from metastatic disease, but children remain at risk for second cancers. In 21.6% of cases ERG function improved. Despite using chemotherapy in both eyes in the same session, systemic toxicity was low.
引用
收藏
页数:11
相关论文
共 41 条
[1]   A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results [J].
Abramson, David H. ;
Dunkel, Ira J. ;
Brodie, Scott E. ;
Kim, Jonathan W. ;
Gobin, Y. Pierre .
OPHTHALMOLOGY, 2008, 115 (08) :1398-1404
[2]  
Abramson David H, 2005, Invest Ophthalmol Vis Sci, V46, P2683
[3]   Treatment of Retinoblastoma in 2015 Agreement and Disagreement [J].
Abramson, David H. ;
Shields, Carol L. ;
Munier, Francis L. ;
Chantada, Guillermo L. .
JAMA OPHTHALMOLOGY, 2015, 133 (11) :1341-1347
[4]  
Abramson David H, 2012, Retin Cases Brief Rep, V6, P209, DOI 10.1097/ICB.0b013e318234ccf4
[5]   Retinoblastoma: Saving Life with Vision [J].
Abramson, David H. .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :171-184
[6]   Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review [J].
Abramson, David H. ;
Marr, Brian P. ;
Brodie, Scott E. ;
Dunkel, Ira ;
Palioura, Sotiria ;
Gobin, Y. Pierre .
PLOS ONE, 2012, 7 (04)
[7]   Chemosurgery for Retinoblastoma What We Know After 5 Years [J].
Abramson, David H. .
ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (11) :1492-1494
[8]   Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' The first Stallard lecture [J].
Abramson, David H. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (04) :396-399
[9]   Bilateral Superselective Ophthalmic Artery Chemotherapy for Bilateral Retinoblastoma: Tandem Therapy [J].
Abramson, David H. ;
Dunkel, Ira J. ;
Brodie, Scott E. ;
Marr, Brian ;
Gobin, Y. Pierre .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (03) :370-372
[10]   A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma [J].
Abramson, DH ;
Frank, CM ;
Dunkel, IJ .
OPHTHALMOLOGY, 1999, 106 (10) :1947-1950